Logo image of ONTEX.BR

ONTEX GROUP NV (ONTEX.BR) Stock Fundamental Analysis

Europe - EBR:ONTEX - BE0974276082 - Common Stock

6.28 EUR
+0.03 (+0.48%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

3

Overall ONTEX gets a fundamental rating of 3 out of 10. We evaluated ONTEX against 13 industry peers in the Personal Care Products industry. ONTEX may be in some trouble as it scores bad on both profitability and health. ONTEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ONTEX had positive earnings in the past year.
In the past year ONTEX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ONTEX reported negative net income in multiple years.
In the past 5 years ONTEX always reported a positive cash flow from operatings.
ONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.44%, ONTEX is doing worse than 69.23% of the companies in the same industry.
The Return On Equity of ONTEX (1.11%) is worse than 69.23% of its industry peers.
ONTEX's Return On Invested Capital of 6.78% is on the low side compared to the rest of the industry. ONTEX is outperformed by 69.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ONTEX is significantly below the industry average of 12.37%.
The 3 year average ROIC (4.39%) for ONTEX is below the current ROIC(6.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROIC 6.78%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ONTEX.BR Yearly ROA, ROE, ROICONTEX.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

With a Profit Margin value of 0.55%, ONTEX is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
ONTEX's Profit Margin has declined in the last couple of years.
ONTEX's Operating Margin of 7.98% is on the low side compared to the rest of the industry. ONTEX is outperformed by 69.23% of its industry peers.
ONTEX's Operating Margin has improved in the last couple of years.
The Gross Margin of ONTEX (29.23%) is worse than 84.62% of its industry peers.
ONTEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
ONTEX.BR Yearly Profit, Operating, Gross MarginsONTEX.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ONTEX is still creating some value.
Compared to 1 year ago, ONTEX has about the same amount of shares outstanding.
Compared to 5 years ago, ONTEX has more shares outstanding
The debt/assets ratio for ONTEX has been reduced compared to a year ago.
ONTEX.BR Yearly Shares OutstandingONTEX.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ONTEX.BR Yearly Total Debt VS Total AssetsONTEX.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.28, we must say that ONTEX is in the distress zone and has some risk of bankruptcy.
ONTEX's Altman-Z score of 1.28 is on the low side compared to the rest of the industry. ONTEX is outperformed by 84.62% of its industry peers.
ONTEX has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as ONTEX would need 6.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.97, ONTEX is doing worse than 61.54% of the companies in the same industry.
ONTEX has a Debt/Equity ratio of 0.72. This is a neutral value indicating ONTEX is somewhat dependend on debt financing.
ONTEX has a Debt to Equity ratio (0.72) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Altman-Z 1.28
ROIC/WACC1.23
WACC5.51%
ONTEX.BR Yearly LT Debt VS Equity VS FCFONTEX.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ONTEX has a Current Ratio of 1.21. This is a normal value and indicates that ONTEX is financially healthy and should not expect problems in meeting its short term obligations.
ONTEX has a Current ratio (1.21) which is comparable to the rest of the industry.
ONTEX has a Quick Ratio of 1.21. This is a bad value and indicates that ONTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, ONTEX is doing worse than 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.81
ONTEX.BR Yearly Current Assets VS Current LiabilitesONTEX.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ONTEX have decreased strongly by -72.09% in the last year.
ONTEX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.62% yearly.
Looking at the last year, ONTEX shows a small growth in Revenue. The Revenue has grown by 3.67% in the last year.
ONTEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%

3.2 Future

ONTEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.84% yearly.
ONTEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.97% yearly.
EPS Next Y-57.18%
EPS Next 2Y-2.66%
EPS Next 3Y0.8%
EPS Next 5Y8.84%
Revenue Next Year-2.14%
Revenue Next 2Y0.08%
Revenue Next 3Y0.85%
Revenue Next 5Y1.97%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ONTEX.BR Yearly Revenue VS EstimatesONTEX.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
ONTEX.BR Yearly EPS VS EstimatesONTEX.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 52.33, which means the current valuation is very expensive for ONTEX.
Based on the Price/Earnings ratio, ONTEX is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.69, ONTEX is valued quite expensively.
With a Price/Forward Earnings ratio of 13.41, ONTEX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ONTEX indicates a rather cheap valuation: ONTEX is cheaper than 92.31% of the companies listed in the same industry.
ONTEX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.18.
Industry RankSector Rank
PE 52.33
Fwd PE 13.41
ONTEX.BR Price Earnings VS Forward Price EarningsONTEX.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ONTEX is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ONTEX is valued cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.01
EV/EBITDA 5.29
ONTEX.BR Per share dataONTEX.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.66%
EPS Next 3Y0.8%

0

5. Dividend

5.1 Amount

No dividends for ONTEX!.
Industry RankSector Rank
Dividend Yield N/A

ONTEX GROUP NV

EBR:ONTEX (10/20/2025, 7:00:00 PM)

6.28

+0.03 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-30 2025-10-30
Inst Owners46.36%
Inst Owner ChangeN/A
Ins Owners3.06%
Ins Owner ChangeN/A
Market Cap517.16M
Analysts78.57
Price Target7.78 (23.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.35%
PT rev (3m)-20.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-53.26%
EPS NY rev (3m)-61.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-5.26%
Valuation
Industry RankSector Rank
PE 52.33
Fwd PE 13.41
P/S 0.28
P/FCF 5.01
P/OCF 2.4
P/B 0.56
P/tB 5.59
EV/EBITDA 5.29
EPS(TTM)0.12
EY1.91%
EPS(NY)0.47
Fwd EY7.46%
FCF(TTM)1.25
FCFY19.97%
OCF(TTM)2.62
OCFY41.71%
SpS22.59
BVpS11.24
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROCE 9.14%
ROIC 6.78%
ROICexc 7.02%
ROICexgc 15%
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
FCFM 5.55%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ROICexc(3y)4.61%
ROICexc(5y)4.96%
ROICexgc(3y)9.94%
ROICexgc(5y)12.9%
ROCE(3y)5.92%
ROCE(5y)5.98%
ROICexcg growth 3Y14.1%
ROICexcg growth 5Y2.75%
ROICexc growth 3Y23.18%
ROICexc growth 5Y5.84%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Debt/EBITDA 3
Cap/Depr 151.69%
Cap/Sales 6.04%
Interest Coverage 3.95
Cash Conversion 96.9%
Profit Quality 1002.91%
Current Ratio 1.21
Quick Ratio 0.81
Altman-Z 1.28
F-Score6
WACC5.51%
ROIC/WACC1.23
Cap/Depr(3y)125.61%
Cap/Depr(5y)112.58%
Cap/Sales(3y)5.05%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
EPS Next Y-57.18%
EPS Next 2Y-2.66%
EPS Next 3Y0.8%
EPS Next 5Y8.84%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
Revenue Next Year-2.14%
Revenue Next 2Y0.08%
Revenue Next 3Y0.85%
Revenue Next 5Y1.97%
EBIT growth 1Y43.9%
EBIT growth 3Y19.21%
EBIT growth 5Y0.28%
EBIT Next Year70.46%
EBIT Next 3Y24.76%
EBIT Next 5Y17.44%
FCF growth 1Y61.15%
FCF growth 3Y11.86%
FCF growth 5Y-5.23%
OCF growth 1Y34.31%
OCF growth 3Y18.3%
OCF growth 5Y-2.03%